Manufacturer record
KamlaAmrut Pharmaceutical LLP: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by KamlaAmrut Pharmaceutical LLP (Gujarat) were declared Not of Standard Quality between September 2022 and November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to KamlaAmrut Pharmaceutical LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Budesonide Nebuliser Suspension BP - 0.5 mg (Budecide? 0.5 mg Nebuliser Solution) | K1090259Mfg 2024-02 · Exp 2026-01 | Related substancesRelated substances | CDTL IndoreCDSCO lab | Nov 2024 |
| Sodium Chloride Injection IP (0.9% w/v) | K4020007Mfg 2023-08 · Exp 2026-07 | Assay of Sodium ChlorideAssay | CDL KolkataCDSCO lab | Nov 2023 |
| BUDISON 0.5 Respules (Budenoside, Nebuliser Suspension BP (0.5 mg) ? 2 ml | K1090046Mfg 2022-02 · Exp 2024-01 | Assay & Related SubstancesAssay | CDL KolkataCDSCO lab | Sep 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.